Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medpace Holdings Inc (NQ: MEDP )

390.91 +4.59 (+1.19%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 107,160
Open 389.72
Bid (Size) 365.35 (1)
Ask (Size) 411.34 (2)
Prev. Close 386.32
Today's Range 385.00 - 392.02
52wk Range 227.21 - 459.77
Shares Outstanding 30,998,636
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
If You Invested $100 In This Stock 5 Years Ago, You Would Have $500 Today
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Dril-Quip, LPL Financial, Methode, and Medpace and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Performance

YTD
+27.92%
+27.92%
1 Month
+2.36%
+2.36%
3 Month
+0.09%
+0.09%
6 Month
-2.68%
-2.68%
1 Year
+54.62%
+54.62%

More News

Read More
Thermo Fisher Scientific Stock Sees RS Rating Jump To 81
Via Investor's Business Daily
If You Invested $100 In This Stock 5 Years Ago, You Would Have $500 Today
Via Benzinga
The Investing Mosaic
Via The Motley Fool
Looking Into Medpace Hldgs's Recent Short Interest
Via Benzinga
Here's How Much $100 Invested In Medpace Hldgs 5 Years Ago Would Be Worth Today
Via Benzinga
Expert Ratings For Medpace Hldgs
Via Benzinga
MEDPACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Medpace Holdings, Inc. on Behalf of Medpace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Medpace Holdings, Inc. (MEDP)
From Kirby McInerney LLP
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Medpace Holdings, Inc. (MEDP) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Medpace Holdings, Inc. (MEDP) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Medpace Holdings, Inc. (MEDP) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Avantor Stock Earns 84 RS Rating
Via Investor's Business Daily
MEDP Investors Have Opportunity to Join Medpace Holdings, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Ford, Stellantis And Dell Are Among Top 12 Large Cap Losers Last Week (July 21-July 27): Are The Others In Your Portfolio?
Via Benzinga
Small-Cap Gains Resume Ahead Of Major Tech Earnings; UPS Faces Worst Day Ever, Bitcoin Dips Below $66,000: What's Driving Markets Tuesday?
Via Benzinga
Why Comcast Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Stocks Bounce As Wall Street Awaits Key Tech Earnings
Via Talk Markets
Topics Stocks
Exposures US Equities
NXP Semiconductors Posts Mixed Q2 Results, Joins Medpace And Other Big Stocks Moving Lower In Tuesday Pre-Market Session
Via Benzinga
US Stock Futures Little Changed As Traders Brace For Q2 Reports From Alphabet, Tesla: 'There Remains Strong Fundamental Support For Large Caps,' Says Economist
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why SAP Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
IBD 50's Medpace Takes A Nosedive After Unexpectedly Slashing Its Sales View
Via Investor's Business Daily
Medpace Holdings Stock Tumbles On Q2 Earnings: What Investors Need To Know
Via Benzinga
Medpace Holdings, Inc. Reports Second Quarter 2024 Results
From Medpace Holdings, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.